LYVE1 and neoplasm: As Lyve-1 can be involved in tumor cell adhesion in vitro, initial tumor cell retention was also assessed in vivo by bioluminescence imaging in Lyve-1-KO and Ctrl mice 90 min after intrasplenic injection of B16F10 luc2 melanoma cells.